Cristin-person-ID: 18100
Person

Åslaug Helland

  • Stilling:
    Overlege
    ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF
  • Stilling:
    Professor
    ved Forskningsleder KRE ved Universitetet i Oslo

Resultater Resultater

Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials.

Eide, Inger Johanne Zwicky; Stensgaard, Simone; Helland, Åslaug; Ekman, Simon; Mellemgaard, Anders; Hansen, Karin Holmskov; Cicenas, Saulius; Koivunen, Jussi; Grønberg, Bjørn Henning; Sørensen, Boe Sandahl mfl.. 2022, Translational Lung Cancer Research (TLCR). VV, KAROLINSKA, OUH, STOLAV, ÅRHUSSYKE, OYS, NTNU, UIO, OUS, GENTOFTE, VUVitenskapelig artikkel

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma.

Khadse, Anand; Haakensen, Vilde Drageset; Silwal-Pandit, Laxmi; Hamfjord, Julian; Micke, Patrick; Botling, Johan; Brustugun, Odd Terje; Lingjærde, Ole Christian; Helland, Åslaug; Kure, Elin Wenche Hegland. 2022, Frontiers in Oncology. VV, Uu, USN, UIO, OUSVitenskapelig artikkel

A national precision cancer medicine implementation initiative for Norway.

Tasken, Kjetil; Russnes, Hege Elisabeth Giercksky; Aas, Eline; Bjørge, Line; Blix, Egil Støre; Ahlquist, Terje C.; Alikhani, Nyosha; Areffard, Mohammad Ali; Bergli, Elise; Edvardsen, Hege mfl.. 2022, Nature Medicine. VV, UIT, MSDNOR, FHI, VESTFOLD, HELSEDIR, HELSENSS, HAUKELAND, INNLANDET, ANDREINST, UNN, STOLAV, PFIZER, JAPAN, SØRLAND, AHUS, OCCI, ØSTFOLD, KREFTREG, DIVNORSK, HELSEFONNA, TELEMARK, ROC, HELSENTRØN, NTNU, KREFTFOR, ASTRA, OUS, APOTEKØST, UIB, SUS, HELSEMR, HELSEFØRDE, UIO, BAY, NOVARTIS, ABBVIE, UISBrev til redaktøren

Concordance between clinical and pathology TNM-staging in lung cancer.

Solberg, Steinar; Nilssen, Yngvar; Brustugun, Odd Terje; Haram, Per Magnus; Helland, Åslaug; Møller, Bjørn; Strand, Trond-Eirik; Wahl, Sissel Gyrid Freim; Fjellbirkeland, Lars. 2022, Lung Cancer. VV, UIT, STOLAV, UIO, OUS, KREFTREGVitenskapelig artikkel

Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5).

Helland, Åslaug; Russnes, Hege Elisabeth Giercksky; Fagereng, Gro Live; Al-Shibli, Khalid Ibrahim; Andersson, Yvonne; Berg, Thomas; Bjørge, Line; Blix, Egil Støre; Bjerkehagen, Bodil; Brabrand, Sigmund mfl.. 2022, Journal of Translational Medicine. UIT, FHI, VESTFOLD, HELSENSS, HAUKELAND, INNLANDET, ANDREINST, STOLAV, UNN, LDS, AHUS, SØRLAND, ØSTFOLD, KREFTREG, HELSEFONNA, TELEMARK, HELSENTRØN, NTNU, OUS, UIB, SUS, HELSEMR, HELSEFØRDE, UIO, UISErrata
1 - 5 av 190 | Neste | Siste »